Neuropathology Mapping | Quantitate beta amyloid, synuclein, and tau load in different brain regions

Use Case: Quantitate beta amyloid, synuclein, and tau load in different brain regions

Quantitate unbiased brain-wide biomarker quantification:

Measure insights
into pathological progression

Non human primates and human clinical sample support:

Quantitate the number and regional occupancy of protein aggregates in transgenic mouse models of neurodegenerative disease after perturbing cell signaling pathways.
Measure the effectiveness of therapeutic interventions on beta amyloid plaque load for treatment of Alzheimer’s Disease.
Study the biology of protein aggregate formation and spread across neural circuits throughout the brain.

For additional publications supporting this use case refer to:

  • Hoglund et al. (2024) Actaneuropathologica
  • Jiang et al. (2024) Frontiers in Neuroscience
  • Chen et al. (2023) PNAS
  • Soula et al. (2023) Nature Neuroscience
  • Martorell et al. (2019) Cell
As scientists ourselves, our expert team collaborates closely with the clients to deliver customized scientific service that meet the unique needs of each study. Get in touch with our application scientists to discuss tailor-engineered solutions for your project.

Speak to an expert about your application